Richard D. Kim
0000-0002-8448-844X
Publication & Citation Trends
Most Cited Works
Publications
316 total
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer
Cited by 0
Semantic Scholar
Targeting the KRAS Oncogene for Patients with Metastatic Colorectal Cancer OA
Cited by 10
Semantic Scholar
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection
Cited by 10
Semantic Scholar
Practice Patterns and Survival Outcomes of Immunotherapy for Metastatic Colorectal Cancer
Cited by 7
Semantic Scholar
Predictive biomarkers for immune checkpoint inhibition for patients with colorectal cancer: a comprehensive review.
Cited by 4
Semantic Scholar
Immunotherapy in MSS/pMMR Metastatic Colorectal Cancer – Insights from the KEYNOTE-651
Cited by 1
Semantic Scholar
Progress in the treatment of anal cancer: an overview of the latest investigational drugs
Cited by 0
Semantic Scholar
Blood Tumor Mutational Burden Alone Is Not a Good Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Gastrointestinal Tumors
Cited by 0
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(84)
Pancreatic and Hepatic Oncology Research
(73)
Cholangiocarcinoma and Gallbladder Cancer Studies
(68)
Hepatocellular Carcinoma Treatment and Prognosis
(51)
Cancer Genomics and Diagnostics
(48)
Frequent Co-Authors
Affiliations
University of North Carolina at Chapel Hill
University of Southern California
Western University
Cedars-Sinai Medical Center
Fox Chase Cancer Center